What is the therapeutic window between insufficient and toxic levels of TDP-43 arginine methylation?
Analysis ID: SDA-2026-04-12-gap-debate-20260410-113051-5dce7651 | Domain: neurodegeneration | Status: completed | Created: 2026-04-12T22:27:52.442709
Knowledge Graph: 2 edges — View JSON
Top Hypotheses (2 total)
#1 p38α Inhibitor and PRMT1 Activator Combination to Restore Physiological TDP-43 Phosphorylation-Methylation Balance
0.615
MAPK14/PRMT1
# p38α Inhibitor and PRMT1 Activator Combination to Restore Physiological TDP-43 Phosphorylation-Methylation Balance
## 1. Mechanism of Action
TAR DNA-binding protein 43 (TDP-43) is a 414-amino-
#2 HSPB1 Phosphorylation Mimetics to Promote Protective TDP-43 Liquid-Liquid Phase Separation
0.598
HSPB1
# HSPB1 Phosphorylation Mimetics to Promote Protective TDP-43 Liquid-Liquid Phase Separation
## Scientific Rationale
TDP-43 pathology constitutes a defining feature of a broad spectrum of neurodeg